| Literature DB >> 20594319 |
Greet Hermans1, Anouk Agten, Dries Testelmans, Marc Decramer, Ghislaine Gayan-Ramirez.
Abstract
INTRODUCTION: Respiratory muscle weakness is an important risk factor for delayed weaning. Animal data show that mechanical ventilation itself can cause atrophy and weakness of the diaphragm, called ventilator-induced diaphragmatic dysfunction (VIDD). Transdiaphragmatic pressure after magnetic stimulation (TwPdi BAMPS) allows evaluation of diaphragm strength. We aimed to evaluate the repeatability of TwPdi BAMPS in critically ill, mechanically ventilated patients and to describe the relation between TwPdi and the duration of mechanical ventilation.Entities:
Mesh:
Year: 2010 PMID: 20594319 PMCID: PMC2945090 DOI: 10.1186/cc9094
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Figure 1Tracheal, esophageal, and abdominal pressure tracings on bilateral magnetic stimulation. Ptr, tracheal pressure; Pes, esophageal pressure; Pabd, abdominal pressure; Pdi, transdiaphragmatic pressure (which was obtained by electronic subtraction of Pabd and Pes).
Figure 2Patient disposition.
Demographic data of patients measured
| Patient number | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Reason for admission | Intestinal perforation and septic shock after redo gastric banding | Cutaneous T-cell lymphoma, generalized weakness | Spondylodiscitis with septic shock | Urosepsis with septic shock | Atrial fibrillation after pneumectomy | Surgical repair of ruptured abdominal aneurysm | Thrombotic, thrombocytopenic purpura | Pyelonephritis with septic shock | Peritonitis | Limbic encephalitis |
| APACHE II | 19 | 11 | 19 | 15 | 14 | 23 | 32 | 28 | 9 | 12 |
| Days after admission | 16 | 17 | 11 | 2 | 11 | 6 | 30 | 8 | 21 | 4 |
| Number of measurements | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 4 |
| TwPdi (cm H2O) | 12.1 | 8.3 | 9.1 | 12.9 | 9.1 | 15.4 | 8.4 | 8.9 | 8.9 | 18.7 |
| Supramaximal stimulation | Yes | Yes | NA | No | Yes | Yes | Yes | NA | No | Yes |
| Sepsis | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
| Dialysis | Yes | No | No | No | No | No | No | No | No | No |
| CS | Yes | No | Yes | Yes | Yes | Yes | Yes | 0 | Yes | Yes |
| AG | Yes | No | No | No | No | Yes | No | No | Yes | No |
| Piritramide mg | 666 | 1,832 | 103 | 60 | 72 | 280 | 764 | 200 | 1032 | 0 |
| Propofol mg | 14,160 | 27,229 | 0 | 15 | 3,460 | 0 | 17,027 | 603 | 15,200 | 0 |
| Vasopressors | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
| NMBA | No | No | Yes | No | No | Yes | Yes | Yes | Yes | No |
| Total duration of MV hours | 555 | 359 | 232 | 49 | 110 | 127 | 700 | 174 | 505 | 65 |
| BIPAP hours | 0 | 232 | 90 | 23 | 0 | 8 | 155 | 53 | 306 | 0 |
| PSV hours | 280 | 127 | 109 | 9 | 110 | 73 | 504 | 107 | 121 | 14 |
| IPPV hours | 275 | 0 | 33 | 17 | 0 | 46 | 41 | 14 | 78 | 51 |
| PEEP at measurement | 5 | 5 | 5 | 5 | 5 | 5 | 7 | 7 | 7 | 5 |
For patients measured on more than one occasion, all data are given for the first measurement. All data concerning dose of medication and duration of mechanical ventilation concern cumulative data from admission to the ICU up to the time of measurement. AG, aminoglycoside; APACHE II, Acute Physiology and Chronic Health Evaluation II; BIPAP, bilevel positive airway pressure; CS, corticosteroids; IPPV, intermittent positive-pressure ventilation; MV, mechanical ventilation; NMBA, neuromuscular blocking agents; PEEP, positive end-expiratory pressure; PSV, pressure-support ventilation; TwPdi, twitch transdiaphragmatic pressure.
Within-occasion coefficient of variation for all measurements
| Patient number | Measurement occasion | Coefficient of variation (%) | |
|---|---|---|---|
| 1 | M1 | 12.1 | 5.6 |
| 1 | M2 | 12.4 | 6.7 |
| 2 | M1 | 8.3 | 3.9 |
| 4 | M1 | 12.9 | 12.2 |
| 4 | M2 | 10.4 | 11.1 |
| 5 | M1 | 9.1 | 9.2 |
| 5 | M2 | 8.3 | 8.8 |
| 6 | M1 | 15.4 | 8.1 |
| 6 | M2 | 15.8 | 8 |
| 7 | M1 | 8.4 | 12.8 |
| 7 | M2 | 10.6 | 2.2 |
| 8 | M1 | 9.2 | 5.2 |
| 9 | M1 | 8.9 | 19.4 |
| 9 | M2 | 11.2 | 1.2 |
| 10 | M1 | 18.7 | 6.0 |
| 10 | M2 | 21.9 | 4.1 |
| 10 | M3 | 18.9 | 2.6 |
| 10 | M4 | 22.3 | 3.4 |
| Mean | 7.25 |
Pdi, transdiaphragmatic pressure.
Between-occasion coefficient of variation for patients receiving measurements on at least two different occasions
| Patient | Number of measurements | Time span between first and last measurement (hours) | Coefficient of variation (%) | |
|---|---|---|---|---|
| 1 | 12.2 | 2 | 24 | 1.9 |
| 4 | 11.7 | 2 | 24 | 15.5 |
| 5 | 8.7 | 2 | 48 | 6.5 |
| 6 | 15.6 | 2 | 48 | 2.0 |
| 7 | 9.5 | 2 | 120 | 16.6 |
| 9 | 10.0 | 2 | 24 | 16.3 |
| 10 | 20.5 | 4 | 72 | 9.3 |
| Mean | 12.6 | 2,3 | 51.4 | 9,7 |
Pdi, transdiaphragmatic pressure.
Figure 3Regression analysis for TwPdi and total duration of mechanical ventilation; cumulative duration of BIPAP/ASB, PSV, and IPPV at the time of measurement; and cumulative dose of piritramide and propofol. All data concern values up to the time of measurement of TwPdi. TwPdi, twitch transdiaphragmatic pressure; BIPAP/ASB, bilevel positive airway pressure with assisted spontaneous breathing; PSV, pressure-support ventilation; IPPV, intermittent positive-pressure ventilation.